Homocystinuria

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
N Neurology/Psychiatry (ATC N) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I (First in Human): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Travere Therapeutics Inc. Commercial
    PEGTIBATINASE
    2023-504135-40-00 8 countries n=22 Orphan
    Pending

Phase I (First in Human)

1 trial
  • Travere Therapeutics Switzerland GmbH Commercial
    PEGTIBATINASE
    2023-509074-31-00 1 country n=6 Orphan
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Travere Therapeutics Inc. Commercial 1 Phase III 0
Travere Therapeutics Switzerland GmbH Commercial 1 Phase I (First in Human) 0
← All indication landscapes